Table 3 |
||||||||
|
Putative target genes for tumorigenesis and tumor progression in recurrent copy number changes of the 16 ESFT patients included in the integration analysis. |
||||||||
|
Symbol |
Name |
Cytoband |
Location1 |
Correlation |
p-value |
Copy number status2 |
q-value |
Functional information |
|
|
||||||||
|
HEATR3 |
HEAT repeat containing 3 |
16q12.1 |
48697286–48697733 |
0,876 |
2,2E-16 |
Deleted |
6,05E-13 |
NA |
|
TRAFD1 |
TRAF-type zinc finger domain containing 1 |
12q24.12 |
111075038–111075556 |
0,853 |
2,2E-16 |
Gained |
6,05E-13 |
[47] |
|
C1orf131 |
Chromosome 1 open reading frame 131 |
1q42.2 |
229426179–229426672 |
0,850 |
2,2E-16 |
Unspecified |
6,05E-13 |
NA |
|
HDGF |
Hepatoma-derived growth factor |
1q21-q23 |
154978607–154979115 |
0,844 |
1,5E-05 |
Gained |
0,024182394 |
|
|
DDX47 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 |
12p13.1 |
12873623– 12874134 |
0,844 |
1,5E-05 |
Gained |
0,024182394 |
[48] |
|
GIGYF2 |
GRB10 interacting GYF protein 2 |
2q37.1 |
233431003–233431539 |
0,838 |
3,5E-05 |
Unspecified |
0,047741159 |
|
|
C2orf49 |
Chromosome 2 open reading frame 49 |
2q12.2 |
105331075–105331416 |
0,832 |
5,9E-05 |
Unspecified |
0,069391132 |
NA |
|
TMEM63A |
Transmembrane protein 63A |
1q42.12 |
224110806–224111244 |
0,829 |
7,3E-05 |
Gained |
0,07491325 |
NA |
|
WDR67 |
WD repeat domain 67 |
8q24.13 |
124233227–124233523 |
0,826 |
8,8E-05 |
Gained |
0,080319015 |
NA |
|
GSDMD1 |
Gasdermin D |
8q24.3 |
144710202–144710602 |
-0,821 |
1,3E-04 |
Gained |
0,107927089 |
NA |
|
GPATCH2 |
G patch domain containing 2 |
1q41 |
215848737–215849264 |
0,812 |
1,8E-04 |
Unspecified |
0,137376561 |
NA |
|
WSB2 |
WD repeat and SOCS box-containing 2 |
12q24.23 |
116955326–116955682 |
0,809 |
2,1E-04 |
Unspecified |
0,142275217 |
[42] |
|
CACNA1C |
Calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
2670999–2671234 |
-0,803 |
2,7E-04 |
Deleted |
0,160672631 |
|
|
KRT79 |
Keratin 79 |
12q13.13 |
51501640–51502010 |
-0,800 |
3,0E-04 |
Unspecified |
0,160672631 |
NA |
|
PPHLN1 |
Periphilin 1 |
12q12 |
41121456–41121979 |
0,797 |
3,2E-04 |
Gained |
0,160672631 |
|
|
C1orf107 |
Chromosome 1 open reading frame 107 |
1q32.2 |
208096981–208097464 |
0,794 |
3,5E-04 |
Gained |
0,160672631 |
NA |
|
FBXL14 |
F-box and leucine-rich repeat protein 14 |
12p13.33 |
1570852–1571348 |
0,794 |
3,5E-04 |
Unspecified |
0,160672631 |
NA |
|
ANKRD11 |
Ankyrin repeat domain 11 |
16q24.3 |
87999533–87999771 |
0,794 |
3,5E-04 |
Deleted |
0,160672631 |
|
|
HEATR1 |
HEAT repeat containing 1 |
1q43 |
234815741–234816376 |
0,791 |
3,9E-04 |
Gained |
0,160672631 |
NA |
|
COG2 |
Component of oligomeric golgi complex 2 |
1q42.2 |
228895774–228896323 |
0,791 |
3,9E-04 |
Gained |
0,160672631 |
[39] |
|
|
||||||||
|
1Location of the Affymetrix target sequence using BLAST algorithm. 2Copy number status = characterization of the copy number status in the whole patient set; unspecified indicates that both amplifications and deletions were found. NA = not available. |
||||||||
|
Savola et al. BMC Cancer 2009 9:17 doi:10.1186/1471-2407-9-17 |
||||||||